Tue, 16 December 2014
In this episode, we discuss two controversial topics in the world of immunizations with Dr. Angelo -- the "high-dose" influenza vaccine and the expanded use of PCV13 (Prevnar-13). |
Tue, 2 December 2014
In this episode, we review HIV therapy with Dr. Cottreau with a particular focus on Truvada, Atripla, Complera, Stribild, and Triumeq. |
Tue, 18 November 2014
In this episode, we discuss the management of overactive bladder, including: oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), trospium (Sanctura), solifenacin (VESIcare), darifenacin (Enablex), fesoterodine (Toviaz), mirabegron (Myrbetriq), and onabotulinumtoxinA (Botox). |
Tue, 4 November 2014
In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum). |
Tue, 21 October 2014
In this episode, we review a wide variety of cancer screening guidelines with a particular focus on the two most controversial screening areas: breast cancer screening with mammography and prostate cancer screening with PSA levels. |
Tue, 7 October 2014
In this episode, we have a roundtable discussion regarding ASHP Midyear and the process of pursuing a pharmacy residency program. |
Tue, 23 September 2014
In this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).
Direct download: 013_-_Obesity_Guidelines_and_Pharmacotherapy.mp3
Category:general -- posted at: 6:00am EST |
Tue, 9 September 2014
In this episode, we review the National Osteoporosis Foundation's osteoporosis guidelines with a particular focus on two newer agents, denosumab (Prolia) and teriparatide (Forteo). |
Tue, 26 August 2014
In this episode, we discuss Bordetella pertussis (whooping cough) with Dr. Michael Fennewald. |
Tue, 12 August 2014
In this episode, we discuss our clinical "pet peeves" covering allergy histories, creatinine clearance, surrogate endpoints, "me too" enantiomer drugs, and dose-dependent pharmacology of psychiatric medications. |
Tue, 29 July 2014
In this episode, we discuss the pharmacology of the renin-angiotensin-aldosterone system and review the evidence for combining ACE-Is, ARBs, and/or DRIs. |
Tue, 15 July 2014
In this episode, we discuss the 2005 ATS/IDSA Healthcare-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia Guidelines (HCAP, HAP, VAP). |
Tue, 1 July 2014
In this episode, we discuss the 2007 ATS/IDSA Community-Acquired Pneumonia (CAP) guidelines. |
Tue, 17 June 2014
In this episode, we discuss updates to the GOLD guidelines for COPD and review the newer agents for COPD including roflumilast (Daliresp), indacaterol (Arcapta Neohaler), aclidinium (Tudorza Pressair), umeclidinium/vilanterol (Anoro Ellipta), and fluticasone/vilanterol (Breo Ellipta). |
Tue, 3 June 2014
In this episode, we discuss smoking cessation, including nicotine replacement therapy, bupropion (Zyban), and varenicline (Chantix). |
Tue, 20 May 2014
In this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT). |
Tue, 6 May 2014
In this episode, we discuss the new drug class of Novel Oral Anticoagulants (NOACs), which include dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis). |
Tue, 22 April 2014
In this episode, we discuss the new JNC 8 guidelines and how these guidelines differ from other hypertension guidelines released in 2013-2014. |
Tue, 8 April 2014
In this episode, we discuss the new, rebranded podcat (HelixTalk) and review the new ACC/AHA 2013 lipid guidelines.
Direct download: HelixTalk_-_Episode_1_lipid_guidelines.mp3
Category:general -- posted at: 6:00am EST |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss women’s health: conjugated estrogens, ethinyl estradiol, norethindrone, norgestrel, etonogestrel, medroxyprogesterone, raloxifene, tamoxifen, miconazole, Midol, phenazopyridine. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss GI medications: methotrexate, allopurinol, mesalamine, esomeprazole, pantoprazole, rabeprazole, sucralfate, dicyclomine, simethicone, pyrantel, and lactase enzyme. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antiemetics, antitussives, and antihistamines: hydroxyzine, meclizine, metoclopramide, prochlorperazine, ondansetron, chlorpheniramine/hydrocodone, promethazine/codeine, desloratadine, dimehydrinate, benzoyl peroxide, and salicylic acid. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss men’s health: terazosin, doxazosin, tamsulosin, finasteride, sildenafil, vardenafil, tadalafil, oxybutynin, tolterodine, minoxidil, and nonoxynol-9. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss muscle relaxants, stimulants, and anticonvulsants: baclofen, carisoprodol, metaxalone, cyclobenzaprine, methylphenidate, Adderall, lisdexamfetamine, phenytoin, divalproex, DEET, tolnaftate, and eucerin. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants and antipsychotics: bupropion, venlafaxine, aripiprazole, quetiapine, risperidone, olanzapine, carbidopa/levodopa, pramoxine, Neosporin, and povidone/iodine. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants: citalopram, escitalopram, sertraline, fluoxetine, paroxetine, duloxetine, amitriptyline, trazodone, fexofenadine, oxymetazoline, and pheniramine. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss sleep agents and neuropathic pain: alprazolam, clonazepam, diazepam, lorazepam, zolpidem, zaleplon, gabapentin, pregabalin, and lidocaine. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for osteoporosis: calcitonin, alendronate, risedronate, ibandronate, potassium chloride, and calcium citrate. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for COPD and asthma: albuterol, levalbuterol, ipratropium, tiotropium, albuterol/ipratropium, fluticasone, mometasone, fluticasone/salmeterol, and formoterol/budesonide. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss opioid analgesics: morphine sulfate, codeine/APAP, oxycodone, oxycodone/APAP, hydrocodone/APAP, hydrocodone/ibuprofen, fentanyl, and bisacodyl. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss pain relivers: meloxicam, celecobix, ketorolac, tramadol, tramadol/APAP, capsaicin, and methyl salicylate. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antifungals and antivirals: fluconazole, itraconazole, ketoconazole, oseltamivir, acyclovir, valacyclovir, docosanol, terbinafine, and clotrimazole or miconazole. |
Tue, 4 March 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antibiotics: metronidazole, clindamycin, doxycycline, nitrofurantoin, sulfamethoxazole/trimethoprim, mupirocin, zinc oxide, and polyethylene glycol 400. |